Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 71
Filter
1.
Eur J Pediatr Surg ; 13(3): 201-5, 2003 Jun.
Article in English | MEDLINE | ID: mdl-12939706

ABSTRACT

We report a patient presenting with severe muscular impairment and chronic intestinal pseudo-obstruction (CIP) at the age of eight months. Due to the aggravated symptoms, assisted ventilation, an ileostomy and total parenteral nutrition were required. Later on, the patient developed a locked-in syndrome (Leigh's subacute necrotising encephalomyelopathy) and finally died due to recurrent pneumonia and chronic renal failure. The assessment of muscle biopsies revealed a moderate single-fibre type II atrophy, a variation of muscle fibre calibre with focal fatty degeneration and a decreased reactivity of cytochrome-c oxidase. Although ragged red fibres had not been found, mitochondrial enzyme activities were markedly decreased with the lowest residual activity detected for NADH:Q1 oxidoreductase and NADH:O2 oxidoreductase (complex I deficiency), thereby confirming the diagnosis of mitochondrial myopathy. A molecular genetic analysis could not identify known mutations of mitochondrial DNA. Gastrointestinal full-thickness biopsies revealed myenteric hypoganglionosis of the colon and stomach and hyperplasia of the submucosal plexus of the ileum. Some of the intestinal smooth muscle cells displayed bulbous protrusions filled with lateralised mitochondria. Mitochondrial myopathies are known to be associated with a variety of clinical syndromes including CIP. However, in contrast to previous reports in which CIP has been attributed to visceral intestinal myopathies, the present case is characterised by neuronal intestinal malformations. Therefore, a mitochondrial myopathy associated with CIP requires a subtle assessment of both the intestinal smooth muscle and the enteric nervous system to identify the underlying pathology.


Subject(s)
Intestinal Pseudo-Obstruction/complications , Mitochondrial Myopathies/complications , Chronic Disease , Colonic Diseases/complications , Colonic Diseases/surgery , Humans , Ileostomy , Infant , Intestinal Pseudo-Obstruction/surgery , Male
2.
Arch Dis Child Fetal Neonatal Ed ; 87(1): F34-6, 2002 Jul.
Article in English | MEDLINE | ID: mdl-12091288

ABSTRACT

BACKGROUND: The pathogenesis of posthaemorrhagic hydrocephalus (PHHC) following intraventricular haemorrhage (IVH) in premature infants includes a fibroproliferative reaction leading to arachnoidal fibrosis, ultimately causing malresorption of cerebrospinal fluid (CSF) at the arachnoid villi. AIMS: To determine whether an increased concentration of the carboxyterminal propeptide of type I procollagen (PICP) in the CSF of neonates after IVH reflects the activation of collagen synthesis preceding the manifestation of PHHC. METHODS: From 20 neonates with PHHC (median birth weight 740 g, median gestational age 25+1 weeks), 52 CSF samples were collected. CSF samples of four neonates (median birth weight 2170 g, median gestational age 32+4 weeks) with congenital non-haemorrhagic hydrocephalus served as controls. PICP was measured by radioimmunoassay. RESULTS: PICP in CSF taken at the start of external CSF drainage (median day 21, range 17-25 days postnatal age) was significantly increased (median 851.5, range 153.5-1944 microg/l) compared with controls (median 136.1, range 33.8-169.5 microg/l). CSF concentrations of PICP declined until permanent shunt placement (median day 70, range days 41-113). CONCLUSION: In neonates who develop PHHC, significant elevation of PICP concentration in the CSF is present 3-4 weeks after IVH. It reflects the increase of local type I collagen turnover, thereby correlating with manifestation of PHHC.


Subject(s)
Cerebral Hemorrhage/cerebrospinal fluid , Hydrocephalus/cerebrospinal fluid , Infant, Premature, Diseases/cerebrospinal fluid , Peptide Fragments/cerebrospinal fluid , Procollagen/cerebrospinal fluid , Birth Weight , Cerebral Hemorrhage/complications , Cerebral Hemorrhage/congenital , Female , Humans , Hydrocephalus/etiology , Infant, Newborn , Infant, Premature , Male , Prospective Studies , Radioimmunoassay/methods
3.
Intensive Care Med ; 23(12): 1275-8, 1997 Dec.
Article in English | MEDLINE | ID: mdl-9470085

ABSTRACT

OBJECTIVE: Case report on the effect of inhaled prostacyclin in a preterm infant (28 weeks gestational age) with respiratory distress syndrome complicated by marked hypoxemia due to persistent pulmonary hypertension of the newborn. Treatment with surfactant, hyperventilation, and elevation of systemic blood pressure had failed to improve oxygenation. MEASURES: A solution containing 10 micrograms PGI2/ml was aerosolized by the SPAG-2 aerosol-generator and then introduced into the afferent loop of the ventilatory circuit. RESULTS: Oxygenation improved dramatically and worsened when aerosolization was withdrawn. Intravenous prostacyclin had no additional effect on oxygenation. We observed no side effects on blood pressure and no bleeding complications. Inhalation was stopped after 40 hours and the baby was successfully weaned from the ventilator after 108 hours. CONCLUSION: Inhaled PGI2 had a beneficial effect on the oxygenation of a preterm neonate with persistent pulmonary hypertension of the newborn.


Subject(s)
Epoprostenol/therapeutic use , Infant, Premature , Persistent Fetal Circulation Syndrome/drug therapy , Respiratory Distress Syndrome, Newborn/complications , Vasodilator Agents/therapeutic use , Administration, Inhalation , Epoprostenol/administration & dosage , Humans , Hypoxia/etiology , Infant, Newborn , Treatment Outcome , Vasodilator Agents/administration & dosage , Ventilator Weaning
4.
Ann Neurol ; 31(6): 669-71, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1514778

ABSTRACT

Neurology in the twentieth century has undergone extraordinary change, particularly in the past 40 years. We trace the major trends, including the growth of the field, the technological advances, the revolution in neuroscience, the emergence of neurology as a free-standing specialty, the rise of child neurology, and the development of neurological subspecialization. Subsequent articles in this series will expand on these subjects.


Subject(s)
Neurology/trends , History, 20th Century , Humans , Medicine/trends , Neurology/education , Neurology/history , Pediatrics/trends , Societies, Medical/history , Specialization , United States , Workforce
8.
Arch Neurol ; 46(3): 326-9, 1989 Mar.
Article in English | MEDLINE | ID: mdl-2645860
11.
JAMA ; 254(15): 2120-2, 1985 Oct 18.
Article in English | MEDLINE | ID: mdl-3900447
12.
Neurology ; 34(10): 1357-61, 1984 Oct.
Article in English | MEDLINE | ID: mdl-6384818
14.
Heart Lung ; 11(6): 516-21, 1982.
Article in English | MEDLINE | ID: mdl-6922851

ABSTRACT

The diagnosis in patients who have psychiatric or neurologic manifestations as the result of toxins of great variety is not particularly difficult and usually can be achieved with a discerning history and physical examination. The EEG is a useful but not a necessary adjunct. The most difficult of these patients to sort out etiologically are those brought into the hospital, without history, in a flaccid coma or wild delirium or with mild or subtle delirium. The dementias are the main differential diagnosis. The hallmarks of metabolic encephalopathy are reduced awareness and fluctuating attention with defects in orientatioN, interpretation, memory, retention, and recall and with hesitant and clumsy motor performance. Prompt treatment is necessary to preserve the integrity of the master organ, the brain. Delay in treatment may convert metabolic encephalopathy into permanent dementia.


Subject(s)
Brain Diseases, Metabolic/diagnosis , Alcohol Amnestic Disorder/etiology , Alcoholism/complications , Brain Diseases, Metabolic/chemically induced , Brain Diseases, Metabolic/complications , Brain Diseases, Metabolic/etiology , Brain Mapping , Cognition Disorders/etiology , Dementia/diagnosis , Diagnosis, Differential , Electroencephalography , Humans , Memory Disorders/etiology , Phenothiazines/adverse effects , Substance Withdrawal Syndrome/complications , Substance-Related Disorders/complications
15.
JAMA ; 241(20): 2193-4, 1979 May 18.
Article in English | MEDLINE | ID: mdl-430823
16.
JAMA ; 240(23): 2543, 1978 Dec 01.
Article in English | MEDLINE | ID: mdl-712955
17.
JAMA ; 239(24): 2557-8, 1978 Jun 16.
Article in English | MEDLINE | ID: mdl-660786
18.
JAMA ; 237(12): 1205, 1977 Mar 21.
Article in English | MEDLINE | ID: mdl-576456
19.
JAMA ; 237(7): 651, 1977 Feb 14.
Article in English | MEDLINE | ID: mdl-319270
20.
JAMA ; 237(5): 476, 1977 Jan 31.
Article in English | MEDLINE | ID: mdl-576274
SELECTION OF CITATIONS
SEARCH DETAIL
...